TraceLink
LeaderLinking People, Processes and Companies on a Network for Greater Good
Est 2009|Valuation $643M|Raised $174.2M
Published Oct 7, 2026
| Starting Price | Not publicly listed (enterprise quote) | Typically quote-based; licensing model varies (not consistently public) | Not publicly listed (enterprise quote) |
| Primary use case | Life sciences multienterprise connectivity, DSCSA/EPCIS exchange, and orchestration functionality | SAP-centric enterprises requiring serialization/traceability aligned to SAP landscapes | Organizations seeking a traceability/serialization suite integrated with the Antares ecosystem (including rfxcel heritage) |
| Key Strength | Vendor-described network effect / partner connectivity; OPUS integration and partner-onboarding tooling; DSCSA/EPCIS support messaging | Deep ERP adjacency for SAP environments; integrated process control patterns | Traceability lineage and integration with Antares Vision Group portfolio; strengths may include packaging/vision system integrations |
| Key Weakness | Public reviews reference learning curve and cost; procurement complexity; reliance on network adoption | Licensing/implementation complexity; pricing opacity; potentially heavy projects | Pricing opacity; integration complexity; regional/functional fit depends on product scope |
TraceLink vs SAP ATTP
TraceLink vs Antares Vision (rfxcel)
TraceLink vs OPTEL